The purpose of the report is to illustrate the state of the market of Ventricular Assist Devices, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report: https://www.credenceresearch.com/report/ventricular-assist-devices-market
According to the World Health Organization, approximately 17.7 million people died from cardiovascular complications in 2015, which represents 31% of all global deaths. Among these deaths, 7.4 million occurred due to coronary heart disease and 6.7 million due to stroke. Most of the cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity and alcohol abuse, using population wide strategies.
Ventricular assist devices market is segmented into right ventricular assist device, left ventricular assist device and bi-ventricular assist device market. In 2016, the left ventricular assist devices segment is leading market due to factors such as rising number of patients suffering with cardiac complications like cardiomyopathy, stroke and class III & class IV heart failure waiting for a heart transplant. Right ventricular assist devices are anticipated to register faster growth throughout the forecast period 2017-2025 majorly due to rise in number of geriatric patients suffering with cardio-pulmonary complications like congestive heart failure and pulmonary hypertension.
Among the considered application areas, bridge to therapy (BTT) held the largest market for the base year 2016, majorly due to factors such as rising prevalence of congestive heart failure and increasing number of advanced heart failure patients awaiting heart transplantation. Additionally, bridge to destination (BTD) segment will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as non-eligibility of senescent patients for heart transplant, patients deemed too old and compromised immunity to undergo heart transplantation can survive with LVAD throughout their lifespan.
In 2016, North America held the largest revenue share chiefly due to factors such as rising prevalence of cardiovascular disease, existence of advanced healthcare and affordable reimbursement scenario. Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as increasing patient pool suffering with cardiovascular complications, large population addicted to alcohol and smoking, unhealthy eating habits and stress; presence of major players involved in the manufacture of ventricular assist devices and increasing disposable income.
The ventricular assist device market is technologically driven and includes major players such as St. Jude Medical, LLC. HeartWare International, Inc., Reliant Heart, Thoratec Corporation, Abiomed, Berlin Heart, Inc., Cardiac Assist, Inc., Jarvik Heart, Inc., Sun Medical Technology Research Corp., Syncardia System, Inc. etc.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Ventricular Assist Devices buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Ventricular Assist Devices contains:
Analysis and forecast of Ventricular Assist Devices market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Ventricular Assist Devices market;
Assessment and forecast of Ventricular Assist Devices market development;
Financial and business profiles of the leading companies in the Ventricular Assist Devices industry.
– Up to date working Ventricular Assist Devices data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Ventricular Assist Devices for the period 2018 to 2026
– Planned Ventricular Assist Devices additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Ventricular Assist Devices projects by region, key countries, and companies
– Details of major planned Ventricular Assist Devices projects in the world up to 2026
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58590
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290